BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 31343724)

  • 1. Race and ethnicity: Not factors in the prescribing of hydrocodone and codeine-containing products in two pediatric emergency departments.
    Rees CA; Bernhardt MB; Camp EA; Lin JS; Chumpitazi CE
    J Opioid Manag; 2019; 15(3):229-233. PubMed ID: 31343724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Opioid Prescribing in a Pediatric Emergency Department After the Rescheduling of Hydrocodone.
    Chumpitazi CE; Rees CA; Camp EA; Bernhardt MB
    J Emerg Med; 2017 Apr; 52(4):547-553. PubMed ID: 27727038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Has the rescheduling of hydrocodone changed ED prescribing practices?
    Oehler EC; Day RL; Robinson DB; Brown LH
    Am J Emerg Med; 2016 Dec; 34(12):2388-2391. PubMed ID: 27776785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of opioid prescribing after rescheduling of hydrocodone-containing products.
    Bernhardt MB; Taylor RS; Hagan JL; Patel N; Chumpitazi CE; Fox KA; Glover C
    Am J Health Syst Pharm; 2017 Dec; 74(24):2046-2053. PubMed ID: 29222361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicians' intention to prescribe hydrocodone combination products after rescheduling: A theory of reasoned action approach.
    Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat M; Sawant RV; Ferries E; Reeve K; Todd KH
    Res Social Adm Pharm; 2017; 13(3):503-512. PubMed ID: 27567741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Increased Hydrocodone Regulation on Opioid Prescribing in an Urban Safety-Net Health Care System.
    Northrup TF; Carroll K; Suchting R; Villarreal YR; Zare M; Stotts AL
    J Am Board Fam Med; 2019; 32(3):362-374. PubMed ID: 31068400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Enforcement Administration Rescheduling of Hydrocodone Combination Products Is Associated With Changes in Physician Pain Management Prescribing Preferences.
    Fleming ML; Driver L; Sansgiry SS; Abughosh SM; Wanat MA; Varisco TJ; Pickard T; Reeve K; Todd KH
    J Pain Palliat Care Pharmacother; 2019; 33(1-2):22-31. PubMed ID: 31454279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacists' perceptions regarding the impact of hydrocodone rescheduling on prescription volume, workflow management, and patient outcomes.
    Varisco TJ; Ogunsanya ME; Barner JC; Fleming ML
    J Am Pharm Assoc (2003); 2017; 57(2S):S51-S62. PubMed ID: 28292504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in hydrocodone combination product exposures reported to California Poison Control System (CPCS) following DEA rescheduling.
    Wu A; Phan C; Nguyen KC; Quindoy M; Lewis J; Apollonio DE
    Clin Toxicol (Phila); 2021 Apr; 59(4):313-319. PubMed ID: 32840386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center.
    Schultz S; Chamberlain C; Vulcan M; Rana H; Patel B; Alexander JC
    J Opioid Manag; 2016; 12(2):119-22. PubMed ID: 27194196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decline in opioid prescribing after federal rescheduling of hydrocodone products.
    Raji MA; Kuo YF; Adhikari D; Baillargeon J; Goodwin JS
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):513-519. PubMed ID: 29271049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population.
    Tran S; Lavitas P; Stevens K; Greenwood BC; Clements K; Alper CJ; Lenz K; Price M; Hydery T; Arnold JL; Takeshita M; Bacon R; Peristere JP; Jeffrey PL
    J Manag Care Spec Pharm; 2017 May; 23(5):532-539. PubMed ID: 28448772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of more restrictive hydrocodone rescheduling on unintentional pediatric opioid exposures.
    Mallama C; Karami S; Zhang D; Zhao Y; Yang Y; Woods C; Ding Y; Meyer T; McAninch J
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5793. PubMed ID: 38783553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Opioid Prescription Practice Changes Due to Hydrocodone Combination Product Rescheduling in an Academic Pain Clinic.
    Ngo J; Parker D; Meroney M; Mitchell J; Veloz O; Lee O; Cunningham KA; Wilkes D
    J Pain Res; 2020; 13():2163-2168. PubMed ID: 32922067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Hydrocodone Schedule Change With Opioid Prescriptions Following Surgery.
    Habbouche J; Lee J; Steiger R; Dupree JM; Khalsa C; Englesbe M; Brummett C; Waljee J
    JAMA Surg; 2018 Dec; 153(12):1111-1119. PubMed ID: 30140896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Provider Prescribing Patterns After Implementation of an Emergency Department Prescription Opioid Policy.
    Osborn SR; Yu J; Williams B; Vasilyadis M; Blackmore CC
    J Emerg Med; 2017 Apr; 52(4):538-546. PubMed ID: 28111065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Rescheduling Hydrocodone on Opioid Prescribing in Ohio.
    Liu Y; Baker O; Schuur JD; Weiner SG
    Pain Med; 2020 Sep; 21(9):1863-1870. PubMed ID: 31502638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of hydrocodone rescheduling on opioid use outcomes: A systematic review.
    Usmani SA; Hollmann J; Goodin A; Hincapie-Castillo JM; Adkins LE; Ourhaan N; Oueini R; Bhagwandass H; Easey T; Vouri SM
    J Am Pharm Assoc (2003); 2021; 61(2):e20-e44. PubMed ID: 33127312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescribers' perceptions on the impact of hydrocodone rescheduling on geriatric pain management: A qualitative study.
    Fernandez J; Thornton JD; Rege S; Lewing B; Bapat S; Xu Q; Fleming ML
    J Opioid Manag; 2018; 14(5):317-326. PubMed ID: 30387855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid Prescribing in a Cross Section of US Emergency Departments.
    Hoppe JA; Nelson LS; Perrone J; Weiner SG; ;
    Ann Emerg Med; 2015 Sep; 66(3):253-259.e1. PubMed ID: 25952503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.